CZC-54252 [1191911-27-9]
C9808
![LKT Laboratories](https://www.bio-connect.nl/wp-content/uploads/2024/02/LKT-Laboratories_logo.png)
Estimated Purity≥98%
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product NameCZC-54252 [1191911-27-9]
- Delivery Days Customer7
- Estimated Purity≥98%
- Format100mM in DMSO
- Scientific DescriptionLRRK2 inhibitor.; SCHEMBL1460537; CHEBI:78414; BCP15148
- Storage Instruction-20°C
- UNSPSC12352200
References
- Kramer T, Lo Monte F, Göring S, et al. Small molecule kinase inhibitors for LRRK2 and their application to Parkinson's disease models. ACS Chem Neurosci. 2012 Mar 21;3(3):151-60. PMID: 22860184. Ramsden N, Perrin J, Ren Z, et al. Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson's disease-related toxicity in human neurons. ACS Chem Biol. 2011 Oct 21;6(10):1021-8. PMID: 21812418.